<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To evaluate the KRAS, BRAF, EGFR, and HER2 gene status in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> by novel techniques and evaluate whether anti-HER2 therapies could be offered in the treatment of these patients </plain></SENT>
<SENT sid="1" pm="."><plain>There are conflicting data on the prevalence of BRAF mutations and EGFR and HER2 gene amplification in colorectal KRAS <z:mp ids='MP_0002169'>wild type</z:mp> patients </plain></SENT>
<SENT sid="2" pm="."><plain>In our study we tried to evaluate these expressions and their relationship to future treatment assays </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical-pathological data and paraffin-embedded specimens were collected from 186 patients who underwent colorectal resections at General Yag√ºe Hospital in Burgos, Spain </plain></SENT>
<SENT sid="4" pm="."><plain>KRAS and BRAF status was analyzed by real-time PCR in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="5" pm="."><plain>EGFR and HER2/<z:chebi fb="1" ids="23995">NEU</z:chebi> gene amplification was detected using fluorescent in situ hybridisation technique (FISH) in 38 KRAS and BRAF <z:mp ids='MP_0002169'>wild type</z:mp> patients </plain></SENT>
<SENT sid="6" pm="."><plain>KRAS mutations were present in 48% of the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>BRAF mutations were present in 6.25% of the KRAS <z:mp ids='MP_0002169'>wild type</z:mp> patients </plain></SENT>
<SENT sid="8" pm="."><plain>EGFR and HER2 gene amplification was observed in 5.3% and 26.3%, respectively, of KRAS and BRAF <z:mp ids='MP_0002169'>wild type</z:mp> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain>HER2, but not EGFR gene amplification, was frequently observed in KRAS and BRAF <z:mp ids='MP_0002169'>wild type</z:mp> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="10" pm="."><plain>These data indicate that HER2 amplification could be one of the genes to be considered in the therapeutic management of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>